Epidemiology of chronic kidney disease in France;Épidémiologie de l'insuffisance rénale chronique en France

Presse Medicale

Volumn 36, Issue 12 II, 2007, Pages 1811-1821

  Stengel, Bénédicte ^a   Couchoud, Cécile ^b   Helmer, Catherine ^a   Loos Ayav, Carole ^a   Kessler, Michèle ^c  

^a INSERM   (France)

^b AGENCE DE LA BIOMÉDECINE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BODY SURFACE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; DISEASE SEVERITY; FRANCE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; NEPHRECTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREVALENCE; RENAL REPLACEMENT THERAPY; SHORT SURVEY; URINARY TRACT INFECTION; ARTICLE; CHRONIC DISEASE; CLASSIFICATION; HOSPITALIZATION; INCIDENCE; KIDNEY DISEASE; RISK FACTOR; SURVIVAL;

CHRONIC DISEASE; FRANCE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY DISEASES; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 36348971895     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.04.039     Document Type: Short Survey

References (30)

1. ESRD Incidence Study Group, and McCredie M. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrol Dial Transplant 21 (2006) 2178-2183 (Epub 2006 Apr 4)
2. Macron-Noguès F., Vernay M., Ekong E., Salanave B., Revel M., Fender P., et al. The prevalence of end-stage kidney disease treated with renal dialysis in France in 2003. Am J Kidney Dis 46 (2005) 309-315
3. Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés. Enquête nationale Schéma d'Organisation Sanitaire de l'Insuffisance Rénale Chronique Terminale (SROS/IRCT) -Juin 2003. Volet Dépenses. Octobre 2005.
4. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al., American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease. Circulation 108 (2003) 2154-2169
5. Agence Nationale d'Accréditation et d'Evaluation en Santé. Recommandations pour la pratique clinique. Diagnostic de l'insuffisance rénale chronique chez l'adulte. Septembre 2002.
6. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, Classification and Stratification. Am J Kidney Dis 39 2 Suppl (2002) S1-S266
7. Coresh J., Astor B., Greene T., Eknoyan G., and Levey A. Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 16 (2005) 180-188
8. Hallan S.I., Coresh J., Astor B.C., Astor B.C., Asberg A., Romundstad S., et al. International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk. J Am Soc Nephrol 17 (2006) 2275-2284
9. Klag M.J., Whelton P.K., Randall B.L., Neaton J.D., Brancati F.L., Ford C.E., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334 (1996) 13-18
10. Brancati F.L., Whelton P.K., Randall B.L., Neaton J.D., Stamler J., and Klag M.J. End-stage renal disease risk in diabetes mellitus : a prospective cohort study of 332,544 men screened for MRFIT. JAMA 278 (1997) 2035-2122
11. Orth S.R., Ritz E., and Schrier R.W. The renal risks of smoking. Kidney Int 51 (1997) 1669-1677
12. Kurella M., Lo J.C., and Chertow G.M. Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults. J Am Soc Nephrol 16 (2005) 2134-2140
13. Taal M.W., and Brenner B.M. Predicting initiation and progression of chronic kidney disease : Developing renal risk scores. Kidney Int 70 (2006) 1694-1705
14. Keith D.S., Nichols G.A., Gullion C.M., Brown J.B., and Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch. Intern. Med. 164 6 (2004) 659-663 (22)
15. Evans M., Fryzek J.P., Elinder C.G., Cohen S.S., McLaughlin J.K., Nyren O., et al. The natural history of chronic renal failure : results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 46 (2005) 863-870
16. Eriksen B.O., and Ingebretsen O.C. The progression of chronic kidney disease : a 10-year population-based study of the effects of gender and age. Kidney Int 69 (2006) 375
17. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
18. Froissart M., Rossert J., Jacquot C., Paillard M., and Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16 (2005) 763-773
19. Froissart M., and Rossert J. Comment estimer la fonction rénale des sujets âgés?. Rev Prat 55 (2005) 2223-2229
20. Agence Nationale d'Accréditation et d'Evaluation en Santé. Recommandations pour la pratique clinique. Indications de l'épuration extra-rénale dans l'insuffisance rénale chronique terminale. Septembre 1996. Nephrologie 18 (1997) 1-274
21. Couchoud C., Stengel B., and Jacquelinet C. Rapport Rein. Nephrol. Ther. 3 supp. 1 (2007) S1-S82
22. Registry ERA-EDTA. ERA-EDTA Registry 2004 Annual Report. Academic Medical Center, Amsterdam, The Netherlands, July 2006. www.era-edta-reg.org.
23. US Renal Data System. USRDS 2006 Annual Data Report : Atlas of end-stage renal disease in the United States, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006. www.usrds.org.
24. Halimi S., Zmirou D., Benhamou P.Y., Balducci F., Zaoui P., Maghlaoua M., et al. Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart (UREMIDIAB 2 Study). Diabetes Metab 25 (1999) 507-512
25. Stengel B., Billon S., van Dijk P.C.W., Jager K., Dekker F.W., Simpson K., et al., on behalf of the ERA-EDTA Registry Committee. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe 1990-1999. Nephrol Dial Transplant 18 (2003) 1824-1833
26. Agence Nationale d'Accréditation et d'Evaluation en Santé. Recommandations pour la pratique clinique. Moyens thérapeutiques pour ralentir la progression de l'insuffisance rénale chronique chez l'adulte. Septembre 2004.
27. Drey N., Roderick P., Mullee M., and Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 42 (2003) 677-684
28. Magnason R.L., Indridason O.S., Sigvaldason H., Sigfusson N., and Palsson R. Prevalence and progression of CRF in Iceland : a population-based study. Am J Kidney Dis 40 (2002) 955-963
29. 3C Study Group.Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 22 (2003) 316-325
30. Stengel B., Jaussent I., Guiserix J., Bourgeon B., Favier F., and et le groupe de l'étude Rédia. Prévalence élevée de maladie rénale chronique à l'Ile de la Réunion : Etude Rédia (REUnion-DIAbète), 1999-2001. Bulletin Epidémiologique Hebdomadaire. 37-38 (2005) 193-194